Ravulizumab
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation. It can be used for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Product Specifications
CAS Number
1803171-55-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Complement System
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Anti-IL-2-R [CD25] (Interleukin-2-receptor) Monoclonal Antibody [IL2R.1]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MC-042 1 Each
Anti-IL-2-R [CD25] (Interleukin-2-receptor) Monoclonal Antibody [IL2R.1]
Sign In for Pricing
View Details 
![Rabbit Polyclonal SMG1 Antibody [Alexa Fluor 750]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NB100-2320AF750 0.1 mL
Rabbit Polyclonal SMG1 Antibody [Alexa Fluor 750]
Sign In for Pricing
View Details